Literature DB >> 4087991

[Nimodipine (Bay e 9736) a new therapy concept in diseases of the inner ear?].

H M Theopold.   

Abstract

In an open study 30 patients with the symptom of tinnitus were treated for 12 weeks with nimodipin (Bay e 9736) 3 X 30 mg/die. 12 patients showed sudden deafness with a history of one day up to more than 20 years. In six cases we observed complete remission, in two cases remission up to 70-80%, in two cases slight improvement. Four patients showed no side reaction to the treatment of nimodipin. Ten patients suffered from so-called degenerative inner ear deafness. 3 (n = 10) showed complete remission, one nearly 90% improvement, another patient showed 60% improvement, one slight improvement, in 4 patients tinnitus persisted. Vertigo-Morbus Menière: 4 out of 30 patients were included with the diagnosis of Morbus Menière with tinnitus. 3 (n = 4) showed complete remission of tinnitus, normal hearing level and no more symptoms of vertigo after 12 or less weeks of treatment with nimodipin. In one case with an history over more than 20 years only the vertigo could be cured. Traumatic inner ear deafness is not apt to be treated with an agent such as nimodipin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4087991

Source DB:  PubMed          Journal:  Laryngol Rhinol Otol (Stuttg)        ISSN: 0340-1588


  6 in total

1.  Alteration of loosely bound calcium in the guinea pig organ of Corti after treatment with diltiazem as calcium channel blocker.

Authors:  U R Heinrich; J Maurer; W Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

2.  PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLD.

Authors:  R Salvi; E Lobarinas; W Sun
Journal:  Drugs Future       Date:  2009       Impact factor: 0.148

3.  The effect of nimodipine on salicylate ototoxicity in the rat as revealed by the auditory evoked brain-stem response.

Authors:  I S Kay; W E Davies
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

Review 4.  Emerging pharmacotherapy of tinnitus.

Authors:  Berthold Langguth; Richard Salvi; Ana Belén Elgoyhen
Journal:  Expert Opin Emerg Drugs       Date:  2009-12       Impact factor: 4.191

5.  Acoustic over-exposure triggers burst firing in dorsal cochlear nucleus fusiform cells.

Authors:  Nadia Pilati; Charles Large; Ian D Forsythe; Martine Hamann
Journal:  Hear Res       Date:  2011-11-07       Impact factor: 3.208

6.  Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience.

Authors:  D Monzani; M R Barillari; M Alicandri Ciufelli; E Aggazzotti Cavazza; V Neri; L Presutti; E Genovese
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-12       Impact factor: 2.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.